Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026)
Quest Diagnostics' (DGX) quarterly Income from Non-Controlling Interests came in at $12.0 million in Q1 2026, down 20.0% year-on-year from $15.0 million in Q1 2025, and up 9.09% quarter-over-quarter from $11.0 million in Q4 2025.
Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Quest Diagnostics has disclosed Income from Non-Controlling Interests across 18 years of filings, most recently posting $12.0 million for Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at $12.0 million, down 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.0 million (changed 0.0% YoY), and the FY2025 annual result was $54.0 million, up 8.0% from the prior year.
- Income from Non-Controlling Interests came in at $12.0 million for Q1 2026 at Quest Diagnostics, up from $11.0 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $20.0 million in Q3 2022 to a low of $11.0 million in Q2 2024.
- The 5-year median for Income from Non-Controlling Interests is $14.0 million (2023), against an average of $14.1 million.
- Across the five-year window, Income from Non-Controlling Interests tumbled 40.0% in 2023 and climbed 27.27% in 2025, its largest moves.
- Quest Diagnostics' Income from Non-Controlling Interests stood at $15.0 million in 2022, then slipped by 13.33% to $13.0 million in 2023, then grew by 7.69% to $14.0 million in 2024, then retreated by 21.43% to $11.0 million in 2025, then climbed by 9.09% to $12.0 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $12.0 million (Q1 2026), $11.0 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 12.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 15.00 Mn |
| Dec 31, 2022 | 15.00 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | 16.00 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 23.00 Mn |
| Sep 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 19.00 Mn |